HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention?

Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy.

n engl j med 375;21 nejm.org November 24, 2016 paid. In other words, Congress is always free to refuse to honor its debts — and it has refused to honor these particular debts. The Republicans acknowledge that an existing, permanent appropriation known as the Judgment Fund normally allows the executive branch to settle lawsuits against the United States. By its terms, however, the Judgment Fund ...

HIV vaccines: good news or bad?

The paper reviewed on the preceding page1 has received much media attention, and has featured in Elisabeth Pisani’s blog, ‘Sex and Science’. I felt it could be helpful to Journal readers if I also reviewed some of the concerns about the HIV vaccine paper2 that were detailed in that blog. Dr Pisani’s blog focuses mainly on specific aspects of the HIV vaccine trial paper:2 approaches taken to sta...

hiv/aids good news and bad news

Are Ghettos Good or Bad?

Your use of the JSTOR archive indicates your acceptance of JSTOR's Terms and Conditions of Use, available at http://www.jstor.org/about/terms.html. JSTOR's Terms and Conditions of Use provides, in part, that unless you have obtained prior permission, you may not download an entire issue of a journal or multiple copies of articles, and you may use content in the JSTOR archive only for your perso...

Hiv-1 Neutralization by Antibodies

12 Los Alamos National Laboratory and New Mexico Consortium, Los Alamos, New Mexico, United 13 States of America 14 Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America 15 Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America 16 Duke University Medical Center, Durham, North Carolina, United States of America 17 US M...